Filing Flows › Krystal Biotech (KRYS) › Recalls, complaints & regulation
Krystal Biotech (KRYS): clinical trials
Krystal Biotech (KRYS) beyond its filings: 11 active clinical trials.
Krystal Biotech's latest quarter
Krystal Biotech, Q3 2026: revenue $127M (+30% year over year), operating margin 55.9%, net earnings $63.1M, operating cash flow $91.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Krystal Biotech have?
11 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.